Values of recombinant tissue type plasminogen activator in the treatment of acute cerebral infarction complicated with atrial fibrillation
10.7501/j.issn.1674-6376.2017.04.017
- VernacularTitle:重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死合并心房颤动患者的临床研究
- Author:
Juanjuan SHA
;
Peihong HOU
;
Bei REN
;
Aixiang ZHANG
- Keywords:
Recombinant tissue type plasminogen activator;
intravenous thrombolysis;
acute cerebral infarction;
atrial fibrillation;
neurological function
- From:
Drug Evaluation Research
2017;40(4):525-528
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the values of recombinant tissue type plasminogen activator (rt-PA)) in the treatment of acute cerebral infarction complicated with atrial fibrillation.Methods Used the prospective research methods,74 patients of acerebral infarction complicated with atrial fibrillation in Xi'an XD Group Hospital from February 2015 to August 2016 were selected and were equally divided into the observation group and the control group accorded to the principle of random envelope drawing.The control group was treated with urokinase intravenous thrombolytic therapy,the observation group was treated with rt-PA intravenous thrombolytic therapy,and the prognosis of the two groups were observed.Results There were no significant differences in gender,age,time window,disease,systolic blood pressure and diastolic blood pressure compared between the two groups.The treatment efficiency in the observation group and control group were 94.6％ and 75.7％,the observation group was significantly higher than that of the control group (P ＜ 0.05).After treatment,the mRS scores in the observation group and the control group were (5.22± 1.83) points and (7.29± 1.45) points,were significantly lower than those before treatment of (10.24± 1.31) points and (10.19 ± 1.52) points (P ＜ 0.05),and the observation group was significantly lower than the control group (P ＜ 0.05).In the observation group,the symptomatic intracerebral hemorrhage and non symptomatic cerebral hemorrhage were 5.4％ and 2.7％ respectively,so that were 18.9％ and 16.2％ in the control group that the observation group were significantly lower than those of the control group (P ＜ 0.05).Conclusion Intravenous thrombolysis with recombinant tissue type plasminogen activator of patients with acute cerebral infarction combined with atrial fibrillation is safe and effective,it can promote the improvement of neurological function,and has good application value.
